Fine Mapping of the Interaction between C4b-Binding Protein and Outer Membrane Proteins LigA and LigB of Pathogenic Leptospira interrogans

PLoS Neglected Tropical Diseases

Volumn 9, Issue 10, 2015, Pages

  Breda, Leandro C D ^a   Hsieh, Ching Lin ^b   Castiblanco Valencia, Mónica M ^a   da Silva, Ludmila B ^c   Barbosa, Angela S ^c   Blom, Anna M ^d   Yung Fu, Chang ^b   Isaac, Lourdes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Department of Obstetrics Gynecology   (United States)

^c INSTITUTO BUTANTAN   (Brazil)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT CONTROL PROTEIN 7; COMPLEMENT CONTROL PROTEIN 8; COMPLEMENT FACTOR H; HEPARIN; LEPTOSPIROSIS VACCINE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN LIGA; OUTER MEMBRANE PROTEIN LIGB; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; COMPETITIVE BINDING ASSAY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOTHERAPY; INFLAMMATION; IONIC STRENGTH; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; NONHUMAN; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN ANALYSIS;

BACTERIAL OUTER MEMBRANE PROTEINS; COMPLEMENT C4B-BINDING PROTEIN; HOST-PATHOGEN INTERACTIONS; HUMANS; LEPTOSPIRA INTERROGANS; PROTEIN INTERACTION MAPPING;

EID: 84949906868     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004192     Document Type: Article

References (67)

1. Levett PN, Leptospirosis. Clin Microbiol Rev. 2001. 14, 296–326. 11292640
2. Inada R, Ido Y, Hoki R, Kakeno R, Ito H, The etiology, mode of infection and specific therapy of Weil’s disease [Spirochaeta icterohaemorrhagiae]. J. Exp. Med. 1916. 23, 377–403. 19867994
3. World Health Organization. Human Leptospirosis: guidance for diagnosis, surveillance and control. 2003. http://whqlibdoc.who.int/hq/2003/WHO_CDS_CSR_EPH_2002.23.pdf.
4. Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D, Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med. Wkly. 2004. 12, 347–52.
5. Adler B, de la Peña Moctezuma A, Leptospira and Leptospirosis. Vet. Microbiol. 2010. 140, 287–96. 19345023
6. Koizumi N, Watanabe W, Leptospiral immunoglobulin-like proteins elicit protective immunity.Vaccine. 2004. 22, 1545–52. 15063580
7. Palaniappan RU, Chang YF, Hassan F, McDonough SP, Pough M, Barr SC, et al. Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA. J Med Microbiol. 2004. 53, 975–984. 15358819
8. Palaniappan RU, Chang YF, Jusuf SS, Artiushin S, Timoney JF, McDonough SP, et al. Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun. 2002. 70, 5924–5930. 12379666
9. Lin YP, Chang YF, A domain of the Leptospira LigB contributes to high affinity binding of fibronectin. Biochem. Biophys. Res. Commun. 2007. 362, 443–8. 17707344
10. Choy HA, Kelley MM, Chen TL, Møller AK, Matsunaga J, Haak DA, Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun. 2007. 75, 2441–50. 17296754
11. Lin YP, Lee DW, McDonough SP, Nicholson LK, Sharma Y, Chang YF, Repeated domains of leptospira immunoglobulin-like proteins interact with elastin and tropoelastin. J. Biol. Chem. 2009. 284, 19380–91. doi: 10.1074/jbc.M109.00453119473986
12. Figueira CP, Croda J, Choy HA, Haake DA, Reis MG, Ko AI, et al.Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin. BMC Microbiol. 2011. 11, 129. doi: 10.1186/1471-2180-11-12921658265
13. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, et al.The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine. 2007. 25, 6277–86. 17629368
14. Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, Chang YF, Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine. 2008. 26, 277–87. 18055070
15. Castiblanco-Valencia MM, Fraga TR, Bezerra da Silva L, Monaris D, Abreu PAE, Strobel S, et al. Leptospiral Immunoglobulin-like Proteins Interact with Human Complement Regulators Factor H, FHL-1, FHR-1, and C4BP. J. Infec. Dis. 2012. 205, 995–1004.
16. Barbosa AS, Monaris D, Silva LB, Morais ZM, Vasconcellos SA, Cianciarrullo AM, et al. Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect. Immun. 2010. 78, 3207–16. doi: 10.1128/IAI.00279-1020404075
17. Silva LB, Miragaia LD, Breda LC, Abe CM, Schmidt MC, Moro AM, et al. Pathogenic Leptospira acquire Factor H and vitronectin via the surface protein LcpA. Infect Immun. 2015. 83, 888–97. doi: 10.1128/IAI.02844-1425534939
18. Whaley K, Ruddy S, Modulation of the alternative complement pathway by beta 1 H globulin. J. Exp. Med. 1976. 144, 1147–63. 62817
19. Weiler JM, Daha MR, Austen KF, Fearon DT, Control of the amplification convertase of complement by the plasma protein beta1H. Proc. Natl. Acad. Sci. U S A. 1976. 73, 3268–72. 1067618
20. Pangburn MK, Schreiber RD, Muller-Eberhard HJ, Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J. Exp. Med. 1977. 146, 257–70. 301546
21. De Paula PF, Barbosa JE, Junior PR, Ferriani VPLM, Latorre RDO, Nudelman V, et al. Ontogeny of Complement Regulatory Proteins—Concentrations of Factor H, Factor I, C4b-Binding Protein, Properdin and Vitronectin in Healthy Children of Different Ages and in Adults. Scand. J. Immunol. 2003. 58, 572–7. 14629629
22. Sánchez-Corral P, Garcia OC, Cordoba SR, lsoforms of Human C4b-binding Protein I. Molecular Basis for the C4BP lsoform Pattern and Its Variations in Human Plasma. J. Immunol. 1995. 155, 4030–6. 7561113
23. Fujita T, Gigli I, Nussenzweig V, Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J. Exp. Med. 1978. 148, 1044–51. 702059
24. Daha MR, Van Es LA, Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein. J. Immunol. 1980. 125, 2051–54. 6903579
25. Blom AM, Kask L, Dahlbäck B, CCP1-4 of the C4b-binding protein alfa-chain are required for factor I mediated cleavage of C3b. Mol. Immunol. 2003. 39, 547–56. 12431388
26. Blom AM, Kask L, Dahlbäck B, Structural requirements for the complement regulatory activities of C4b-binding protein. J. Biol. Chem. 2001. 276, 27136–27144. 11369776
27. Blom AM, Webb J, Villoutreix B, Dahlbäck B, A cluster of positively charged amino acids in the N-terminal modules of C4BP α-chain is crucial for the C4b binding and factor I cofactor function. J. Biol. Chem. 1999. 274, 19237–19245. 10383431
28. Hessing M, Vlooswijk RA, Hackeng TM, Kanters D, Bouma BN, The localization of heparin-binding fragments on human C4b-binding protein. J. Immunol. 1990. 144, 204–8. 2136880
29. Dahlbäck B, Stenflo J, High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc. Natl. Acad. Sci. USA. 1981. 78, 2512–6. 6454142
30. Blom AM, Structural and Functional studies of complement inhibitor C4b-binding protein. Biochem. Soc. Trans. 2002. 30, 978–82. 12440957
31. Blom AM, Hallström T, Riesbeck K, Complement evasion strategies of pathogens—acquisition of inhibitors and beyond. Mol. Immunol.2009.46, 2808–17. 19477524
32. Blom AM, Zadura AF, Villoutreix BO, Dahlbäck B, Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. Mol Immunol. 2000. 37, 445–53. 11090879
33. Matsunaga J, Sanchez Y, Xy X, Haake DA, Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun. 2005. 73, 70–815618142
34. Najjam S, Gibbs RV, Gordon MY, Rider CC, Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Cytokine. 1997. 9, 1013–22. 9417813
35. Ching AT, Fávaro RD, Lima SS, Chaves AA, de Lima MA, Nader HB, et al.Leptospira interrogans shotgun phage display identified LigB as a heparin-binding protein. Biochem. Biophys. Res. Commun. 2012. 427, 774–923044419
36. Lawrence JJ, The lysis of leptospires by antiserum. Australian J. Exptl. Biol. Med. Sci.1955. 33, 91–102.
37. Johnson RC, Muschel LH, Antileptospiral activity of normal serum. J. Bacteriol. 1965. 89, 1625–1626. 14291607
38. Johnson RC, Musche LH, Antileptospiral activity of serum. I. Normal and immune serum. J. Bacteriol. 1966. 91, 1403–1409. 5929774
39. Johnson RC, Harris VG, Antileptospiral Activity of Serum II. Leptospiral Virulence Factor. J. Bacteriol. 1967. 93, 513–519. 6020558
40. Meri T, Murgia R, Stefanel P, Meri S, Cinco M, Regulation of complement activation at the C3-level by serum resistant leptospires. Microb. Pathog. 2005. 39, 139–47. 16169184
41. Meri T, Cutler SJ, Blom AM, Meri S, Jokiranta TS, Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect. Immun. 2006. 74, 4157–63. 16790790
42. Grosskinsky S, Schott M, Brenner C, Cutler SJ, Simon MM, Wallich R, Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS. Negl. Trop. Dis. 2010. 4[6]:698.
43. Ngampasutadol J, Ram S, Blom AM, Jarva H, Jerse AE, Lien E, et al. Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc. Nat.l Acad. Sci. USA. 2005.102, 17142–7.
44. Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, Pangburn MK, et al. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med. 1998. 187, 743–52. 9480984
45. Pandiripally V, Gregory R, Cue D, Acquisition of Regulators of Complement Activation by Streptococcus pyogenes Serotype M1. Infect. Immun. 2002. 70, 6206–14. 12379699
46. Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA, Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A. 1988. 85, 1657–61. 2964038
47. Hallström T, Jarva H, Riesbeck K, Blom AM, Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 2007. 178, 6359–66. 17475865
48. Williams BJ, Morlin G, Valentine N, Smith AL, Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect Immun. 2001. 69, 695–705. 11159957
49. Nordström T, Blom AM, Forsgren A, Riesbeck K, The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J. Immunol. 2004. 173, 4598–606. 15383594
50. Bernhard S, Fleury C, Su YC, Zipfel PF, Koske I, Nordström T, et al. Outer membrane protein OlpA contributes to Moraxella catarrhalis serum resistance via interaction with factor H and the alternative pathway. J Infect Dis. 2014. 210, 1306–10. doi: 10.1093/infdis/jiu24124771863
51. Berggård K, Dahlbäck B, Lindahl G, Blom AM, Bordetella pertussis binds to human C4b-binding protein at a site similar to that used by the natural ligand C4b. Eur. J Immunol. 2001.31, 2771–2780. 11536176
52. Amdahl H, Jarva H, Haanperä M, Mertsola J, He Q, Jokiranta TS, et al. Interactions between Bordetella pertussis and the complement inhibitor factor H.Mol Immunol. 2011. 48, 697–705. doi: 10.1016/j.molimm.2010.11.01521167605
53. Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC, A novel interaction of outer membrane protein A with C4b-binding protein mediates serum resistance of Escherichia coli K1. J. Immunol.2002. 169, 6352–6360. 12444142
54. Kubens BS, Wettstein M, Opferkuch W, Two different mechanisms of serum resistance in Escherichia coli. Microb Pathog. 1988. 5, 371–9. 3070267
55. Sahagún-Ruiz A, Granados-Martinez AP, Breda LC, Fraga TR, Castiblanco-Valencia MM, Barbosa AS, et al. Pasteurella pneumotropicaevades the human complement system by acquisition of the complement regulators factor H and C4BP. PLoS One. 2014. 9[10]:e111194. doi: 10.1371/journal.pone.011119425347183
56. Meri T, Blom AM, Hartmann A, Lenk D, Meri S, Zipfel PF, The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect. Immun. 2004. 72, 6633–41. 15501796
57. Vogl G, Lesiak I, Jensen DB, Perkhofer S, Eck R, Speth C, et al. Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. Mol. Immunol. 2008. 45, 1485–93. 17915330
58. Barbosa AS, Abreu PA, Vasconcellos SA, Morais ZM, Gonçales AP, Silva AS, et al. Immune evasion of leptospire species by acquisition of human complement regulator C4BP. Infect. Immun. 2009. 77,1137–43. doi: 10.1128/IAI.01310-0819114549
59. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, et al. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect. Immun. 2006. 74, 1745–50. 16495547
60. Croda J, Ramos JG, Matsunaga J, Queiroz A, Homma A, Riley LW, et al. Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis. J Clin Microbiol. 2007. 45, 1528–34. 17360842
61. Lourdault K, Wang LC, Vieira A, Matsunaga J, Melo R, Lewis MS, et al. Oral immunization with Escherichia coli expressing a lipidated form of LigA protects hamsters against challenge with Leptospira interrogans serovar Copenhageni. Infect Immun. 2013. 82, 893–902. doi: 10.1128/IAI.01533-1324478102
62. Agarwal V, Hammerschmidt S, Malm S, Bergmann S, Riesbeck K, Blom AM, Enolase of Streptococcus pneumoniae Bind Human Complement Inhibitor C4b-Binding Protein and Contributes to Complement evasion. J. Immunol. 2012. 189, 3575–84. 22925928
63. Ho DK, Tissari J, Jarvinen HM, Blom AM, Meri S, Jarva H, Functional Recruitment of Human Complement Inhibitor C4b-Binding Protein to Outer Membrane Protein Rck of Salmonella. PLoS One. 2011. 6[11]:e27546. doi: 10.1371/journal.pone.002754622102907
64. Ho DK, Riva R, Kirjavainen V, Jarva H, Ginström E, Blom AM, et al. Functional Recruitment of the Human Complement Inhibitor C4BP to Yersinia pseudotuberculosis Outer Membrane Protein Ail. J. Immunol. 2012. 188, 4450–9. doi: 10.4049/jimmunol.110314922467648
65. Hallström T, Jarva H, Riesbeck K, Blom AM, Interaction with C4b-Binding Protein Contributes to Nontypeable Haemophilus influenzae Serum Resistance. J. Immunol. 2007. 178, 6359–66. 17475865
66. Potempa M, Potempa J, Okroj M, Popadiak K, Eick S, Nguye KA, et al. Binding of Complement Inhibitor C4b-Binding Protein Contributes to Serum Resistance of Porphyromonas gingivalis. J. Immunol. 2008. 181, 5537–44. 18832711
67. Lin YP, McDonough SP, Sharma Y, Chang YF, The terminal immunoglobulin-like repeats of LigA and LigB of Leptospira enhance their binding to gelatin binding domain of fibronectin and host cells. PLoS One. 2010. 5[6]:e11301. doi: 10.1371/journal.pone.001130120585579